Cargando…
The influences of Taiwan's generic grouping price policy on drug prices and expenditures: Evidence from analysing the consumption of the three most-used classes of cardiovascular drugs
BACKGROUND: Controlling the growth of pharmaceutical expenditures is a major global challenge. Promotion of generic drug prescriptions or use is gaining increased support. There are substantial contextual differences in international experiences of implementing pharmaceutical policies related to gen...
Autores principales: | Chen, Chi-Liang, Chen, Likwang, Yang, Wei-Chih |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377257/ https://www.ncbi.nlm.nih.gov/pubmed/18405385 http://dx.doi.org/10.1186/1471-2458-8-118 |
Ejemplares similares
-
The impact of generics and generic reference pricing on candesartan and rosuvastatin utilisation, price and expenditure in South Africa
por: de Jager, Henk, et al.
Publicado: (2018) -
Pharmacy Benefit Manager Pricing and Spread Pricing for High-Utilization Generic Drugs
por: Mattingly, T. Joseph, et al.
Publicado: (2023) -
An empirical study of the impact of generic drug competition on drug market prices in China
por: Yina, Chen, et al.
Publicado: (2023) -
Pricing Zolgensma – the world’s most expensive drug
por: Nuijten, Mark
Publicado: (2021) -
Does drug price-regulation affect healthcare expenditures?
por: Ben-Aharon, Omer, et al.
Publicado: (2016)